Evidence map›Paper›PMID 35861839›Full record

ArticleJournal of the American Heart Association2022

Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database.

Pamela L Lutsey, Line H Evensen, Thenappan Thenappan, Kurt W Prins, Rob F Walker, Joel F Farley, Richard F MacLehose, Alvaro Alonso, Neil A Zakai

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Advancements in preclinical human-relevant modeling of pulmonary vasculature on-chip.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2024
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Pamela L LutseyDivision of Epidemiology & Community Health School of Public Health University of Minnesota Minneapolis MN.ORCID 0000-0002-1572-1340
Line H EvensenK.G. Jebsen - Thrombosis Research and Expertise Center (TREC) Department of Clinical Medicine UiT The Arctic University of Norway Tromsø Norway.ORCID 0000-0002-7169-9408
Thenappan ThenappanDivision of Cardiovascular Sciences School of Medicine University of Minnesota Minneapolis MN.ORCID 0000-0002-6210-0467
Kurt W PrinsDivision of Cardiovascular Sciences School of Medicine University of Minnesota Minneapolis MN.ORCID 0000-0002-0364-6742
Rob F WalkerDivision of Epidemiology & Community Health School of Public Health University of Minnesota Minneapolis MN.
Joel F FarleyDepartment of Pharmaceutical Care and Health Systems College of Pharmacy University of Minnesota Minneapolis MN.
Richard F MacLehoseDivision of Epidemiology & Community Health School of Public Health University of Minnesota Minneapolis MN.
Alvaro AlonsoDepartment of Epidemiology Rollins School of Public Health Emory University Atlanta GA.ORCID 0000-0002-2225-8323
Neil A ZakaiDivision of Hematology/Oncology Department of Medicine & Department of Pathology and Laboratory Medicine Larner College of Medicine University of Vermont Burlington VT.ORCID 0000-0001-8824-4410
University of Minnesota · USEmory University · USUiT The Arctic University of Norway · NOUniversity of Vermont · US

Funding

GP130 Antagonism in Porcine RV Pressure OverloadR01HL162927 · NHLBI · UNIVERSITY OF MINNESOTA · PI Kurt W Prins · 2022 to 2026
$3.3M
Multi-scale Investigation of Sex Differences in Right Ventricular Function via Estrogen-Microtubule InteractionsR01HL158795 · NHLBI · UNIVERSITY OF MINNESOTA · PI Kurt W Prins · 2022 to 2026
$2.8M
Contemporary Venous Thromboembolism TreatmentR01HL131579 · NHLBI · UNIVERSITY OF MINNESOTA · PI LUTSEY, PAMELA L. · 2017 to 2020
$1.9M
Mechanisms of Junctophilin-2 Misregulation that contribute to right ventricular dysfunction in pulmonary arterial hypertensionK08HL140100 · NHLBI · UNIVERSITY OF MINNESOTA · PI PRINS, KURT W · 2018 to 2022
$785k
Mentoring and Research in Patient-Oriented Cardiovascular PharmacoepidemiologyK24HL159246 · NHLBI · UNIVERSITY OF MINNESOTA · PI PAMELA L. Lutsey · 2021 to 2026
$644k
Mentoring in patient-oriented atrial fibrillation and cardiovascular researchK24HL148521 · NHLBI · EMORY UNIVERSITY · PI ALONSO, ALVARO · 2019 to 2023
$593k
NHLBI NIH HHS K08 HL140100NHLBI NIH HHS K24 HL148521NHLBI NIH HHS K24 HL159246NHLBI NIH HHS R01 HL131579
6 · The paper itself

Abstract

Background Pulmonary hypertension (PH) is a devastating potential complication of pulmonary embolism, a manifestation of venous thromboembolism (VTE). The incidence of and risk factors for PH in those with prior VTE are poorly characterized. Methods and Results

Indexed as

Hypertension, PulmonaryPulmonary EmbolismVenous ThromboembolismAdultAgedDelivery of Health CareFemaleHumansIncidenceMaleMiddle AgedRisk Factorsepidemiologypulmonary hypertensionvenous thromboembolism

Identifiers

PMID35861839
PMCPMC9707844
OpenAlexW4285591394

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.